fashion -WSS

fashion

author：leisure time 2025-09-06 03:58:18 - browse：13885

Adam's take main illustration — Molly Ferguson/STAT

This week, I address pushback I received on my Novartis-MorphoSys column. But first, a preview of the expected readout from Gritstone Bio’s neoantigen cancer vaccine study.

A looming test for neoantigen cancer vaccines

Before the end of the quarter, Gritstone Bio will release preliminary results from a randomized, Phase 2 clinical trial investigating a personalized therapeutic cancer vaccine in microsatellite-stable colon cancer, a type of “immunologically cold” tumor that is resistant to immunotherapies like PD-1/PD-L1 inhibitors.

The Gritstone vaccine is designed to train a patient’s own T cells to recognize and kill cancer cells by targeting mutated cancer proteins, called neoantigens, that are unique to a patient’s own tumor. It’s a relatively new approach for cancer vaccines — made possible by powerful and relatively inexpensive genomic sequencing of tumors – that is intended to overcome all the previous failures in the field. Gritstone’s effort is also similar to one being used by Moderna and Merck that has reported encouraging results in melanoma — and is now being investigated in a Phase 3 study.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Novavax promises a turnaround & Lilly roils the obesity market
Next article： Mayo Clinic plans $5B tech

WSS

BIO selects John Crowley as new CEO

Mindstrong's demise and the future of mental health care

Readout Newsletter: The latest in Pfizer, Moderna, and Sanofi

Diagnostic tests are hitting their mathematical limits

As biotech industry slumps, bioscience job market is upside down

Flagship Pioneering launches a new biotech in two countries

Wikipedia

fashion

A looming test for neoantigen cancer vaccines

knowledge

Moonlake's readout produced a cash windfall. Risks remain

Inequities make cancer less preventable for women: report

Hollywood unions extend contract negotiations for actors

Address the ethical violations that led to 'Three Identical Strangers'

How one medical school became remarkably diverse

Inequities make cancer less preventable for women: report

Cancer drug shortages should be causing more outrage

Senator probes 340B programs at Cleveland Clinic, Bon Secours

New air purifier tech could be key to improving indoor air quality

FDA advisers vote against ALS treatment from BrainStorm

knowledge

The EPA's new lead rule: How one expert crunched the numbers

ReNAgade cuts staff seven months after raising $300 million

How the Dana

FDA advisers vote against ALS treatment from BrainStorm

STAT Virtual Event: How to Increase Diversity in Clinical Trials

UnitedHealth’s Optum accused of antitrust violations in California

hotspot

focus

knowledge

hotspot